MCH ADVISORY RESEARCHMain site ↗
Financials

Financial Exchanges & Data

10 companies under coverage.

Coverage

Financial Exchanges & Data


Equity Research

MSCI Inc (MSCI)

HOLD. 12-month probability-weighted target $550 (+0% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

MSCIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.0%
Equity Research

S&P Global Inc (SPGI)

HOLD. 12-month probability-weighted target $397 (-7% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

SPGIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -10.3%
Equity Research

Moodys Corporation (MCO)

HOLD. 12-month probability-weighted target $457 (-5% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

MCOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.0%
Equity Research

Cboe Global Markets Inc (CBOE)

SELL. 12-month probability-weighted target $235 (-20% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CBOEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -17.7%
Equity Research

FactSet Research Systems Inc (FDS)

SELL. 12-month probability-weighted target $236 (-18% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

FDSEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -18.7%
Equity Research

Morningstar Inc (MORN)

SELL. 12-month probability-weighted target $169 (-16% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

MORNEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.4%
Equity Research

Nasdaq Inc (NDAQ)

SELL. 12-month probability-weighted target $82 (-14% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

NDAQEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -23.8%
Equity Research

CME Group Inc (CME)

SELL. 12-month probability-weighted target $217 (-22% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

CMEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -28.8%
Equity Research

Intercontinental Exchange Inc (ICE)

SELL. 12-month probability-weighted target $123 (-22% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

ICEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -31.6%
Equity Research

Coinbase Global Inc (COIN)

SELL. 12-month probability-weighted target $117 (-35% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

COINEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -46.9%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed